US Patent 9381173 Isolated stereoisomeric forms of (S)2-N(3-O-(propan 2-Ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide
Patent 9381173 was granted and assigned to Novaremed on July, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9381173 Isolated stereoisomeric forms of (S)2-N(3-O-(propan 2-Ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.